30 Grants (Page 1 of 2)
2021
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1P50CA254897-01A1-5654), $376,634USD, 2021-08-16 -- 2026-06-30
2018
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
Matei, Daniela E and Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA182832-05), $291,324USD, 02/14/2014 -- 01/31/2019
2017
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
Matei, Daniela E and Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA182832-04), $290,738USD, 02/14/2014 -- 01/31/2019
 
Therapeutic Targeting Using Tumor-Specific Peptides Inhibits Long Noncoding RNA HOTAIR Oncogenic Activity in High-Grade Serous Ovarian Cancer
Nephew, Kenneth
U.S. Department Of Defense (Dod) (ID: W81XWH1710076), $706,500USD, 5/15/2017 -- 5/14/2020
2015
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
Matei, Daniela E and Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA182832-02), $323,700USD, 02/14/2014 -- 01/31/2019
2014
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
Matei, Daniela E and Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA182832-01), $323,700USD, 02/14/2014 -- 01/31/2019
2012
DNA Methylation and Ovarian Cancer
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA085289-09), $233,953USD, 05/01/2000 -- 02/28/2014
2011
DNA Methylation and Ovarian Cancer
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA085289-08), $234,310USD, 05/01/2000 -- 02/28/2013
 
EAGER: Testing genotype-hormone associations in circumpolar ancestral and descendant populations
Demas, Gregory⋅Renbarger, Jamie⋅Vitzthum, Virginia and Nephew, Kenneth
National Science Foundation (NSF), Office of Polar Programs, Division of Arctic Sciences (ID: 1142201), $299,994USD, 07/01/2011 -- 06/30/2013
2010
DNA Methylation and Ovarian Cancer
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA085289-07), $241,916USD, 05/01/2000 -- 02/28/2013
2009
DNA Methylation and Ovarian Cancer
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA085289-06), $255,015USD, 05/01/2000 -- 02/28/2013
2008
DNA Methylation and Ovarian Cancer
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA085289-05A1), $264,396USD, 05/01/2000 -- 02/28/2013
 
Predicting Drug Resistance in Cancer Genomes by DMA Methylation Profiling
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U54CA113001-05-0004), $396,106USD, 2008
2007
Predicting Drug Resistance in Cancer Genomes by DMA Methylation Profiling
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U54CA113001-04-0004), $433,347USD, 2007
2006
Predicting Drug Resistance in Cancer Genomes by DMA Methylation Profiling
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U54CA113001-03-0004), $276,377USD, 2006
2005
DNA Methylation and Ovarian Cancer
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA085289-04), $265,220USD, 08/01/2002 -- 05/02/2008
 
Predicting Drug Resistance in Cancer Genomes by DMA Methylation Profiling
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5U54CA113001-02-0004), $268,329USD, 2005
2004
DNA Methylation and Ovarian Cancer
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA085289-03), $294,457USD, 08/01/2002 -- 07/31/2006
 
Predicting Drug Resistance in Cancer Genomes by DMA Methylation Profiling
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1U54CA113001-01-0004), $266,461USD, 09/30/2004 -- 08/31/2009
2003
DNA Methylation and Ovarian Cancer
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA085289-02), $295,328USD, 08/01/2002 -- 07/31/2006
2002
DNA Methylation and Ovarian Cancer
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA085289-01A2), $308,015USD, 08/01/2002 -- 07/31/2006
2000
TAMOXIFEN AND RETINOIC ACID EFFECT ON THE UTERUS
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R29CA074748-05), $94,205USD, 09/26/1996 -- 08/31/2001
1999
TAMOXIFEN AND RETINOIC ACID EFFECT ON THE UTERUS
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R29CA074748-04), 09/26/1996 -- 08/31/2001
1998
TAMOXIFEN AND RETINOIC ACID EFFECT ON THE UTERUS
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R29CA074748-03S1), 09/26/1996 -- 08/31/2001
 
TAMOXIFEN AND RETINOIC ACID EFFECT ON THE UTERUS
Nephew, Kenneth P
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R29CA074748-02S1), 09/26/1996 -- 08/31/2001